SPECTRUM BIOMEDICAL, LLC and OPTIMUM BIO, LLC agreed to acquire 31.38% stake in Liminatus Pharma, LLC from Ewon Comfortech Co., Ltd. (KOSDAQ:A088290) for KRW 25.7 billion on March 17, 2023. Liminatus Pharma has total assets of KRW 74.27 billion and KRW 47.57 billion. The Scheduled sale dates is of March 17, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,490 KRW | -0.60% | -1.46% | -17.18% |
1st Jan change | Capi. | |
---|---|---|
-17.18% | 33.11M | |
+6.28% | 8.03B | |
-1.98% | 5.07B | |
-16.34% | 2.78B | |
+2.97% | 2.61B | |
-3.12% | 2.27B | |
+28.26% | 1.77B | |
+35.33% | 1.62B | |
+3.15% | 1.49B | |
-22.93% | 1.43B |
- Stock Market
- Equities
- A088290 Stock
- News Ewon Comfortech Co., Ltd.
- SPECTRUM BIOMEDICAL, LLC and OPTIMUM BIO, LLC agreed to acquire 31.38% stake in Liminatus Pharma, LLC from Ewon Comfortech Co., Ltd. for KRW 25.7 billion.